Ledger.Open graph →
SEC Form D · filed December 5, 2018

Antios Therapeutics Inc

Offering
$25.0M
Sold
$15.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ATLANTA, GA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Abel De La Rosa · Atlanta, GAExec · DirectorDouglas L. Mayers · Atlanta, GAExecScott Morenstein · Atlanta, GADirectorIdean Marvasty · Atlanta, GAExecNicole Vitulio · Atlanta, GADirectorBenjamin Rovinski · Chapel Hill, NCDirectorHenry L. Chen · Grand Cayman, Cayman IslandsDirectorBenjamin Rovinski · Chapel Hill, NCDirectorAbel De La Rosa · Lawrenceville, GAExec · DirectorNicole Vitulio · Atlanta, GADirectorHenry L. Chen · Grand Cayman, Cayman IslandsDirectorDouglas L. Mayers · Atlanta, GAExecScott Morenstein · Malvern, PADirectorIdean Marvasty · Atlanta, GAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗